Correlation Between Pfizer and 172967NN7
Specify exactly 2 symbols:
By analyzing existing cross correlation between Pfizer Inc and C 3785 17 MAR 33, you can compare the effects of market volatilities on Pfizer and 172967NN7 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of 172967NN7. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and 172967NN7.
Diversification Opportunities for Pfizer and 172967NN7
Very weak diversification
The 3 months correlation between Pfizer and 172967NN7 is 0.53. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and C 3785 17 MAR 33 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on C 3785 17 and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with 172967NN7. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of C 3785 17 has no effect on the direction of Pfizer i.e., Pfizer and 172967NN7 go up and down completely randomly.
Pair Corralation between Pfizer and 172967NN7
Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the 172967NN7. In addition to that, Pfizer is 2.81 times more volatile than C 3785 17 MAR 33. It trades about -0.05 of its total potential returns per unit of risk. C 3785 17 MAR 33 is currently generating about 0.0 per unit of volatility. If you would invest 8,856 in C 3785 17 MAR 33 on September 1, 2024 and sell it today you would earn a total of 20.00 from holding C 3785 17 MAR 33 or generate 0.23% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 98.92% |
| Values | Daily Returns |
Pfizer Inc vs. C 3785 17 MAR 33
Performance |
| Timeline |
| Pfizer Inc |
| C 3785 17 |
Pfizer and 172967NN7 Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pfizer and 172967NN7
The main advantage of trading using opposite Pfizer and 172967NN7 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, 172967NN7 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 172967NN7 will offset losses from the drop in 172967NN7's long position.| Pfizer vs. Crinetics Pharmaceuticals | Pfizer vs. Enanta Pharmaceuticals | Pfizer vs. Amicus Therapeutics | Pfizer vs. Connect Biopharma Holdings |
| 172967NN7 vs. PACCAR Inc | 172967NN7 vs. Gentex | 172967NN7 vs. Marine Products | 172967NN7 vs. FDG Electric Vehicles |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Other Complementary Tools
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |